← European Medicine Shortage Tracker · all medicines
Gliclazida currently has availability issues reported in 3 European registers: Austria, Spain, Italy.
Shortage ATC — · also listed as: GLICLAZID · GLICLAZIDA · GLICLAZIDE · data refreshed 7 August 2026
As of 7 August 2026, 3 of the 10 tracked registers list current availability issues for Gliclazida, covering 7 affected product presentations. The longest-running open report was filed in Italy on 2025-01-31 and has now been open for about 19 months. Where agencies state a cause, manufacturing problems lead with 4 of the 4 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-29; the earliest is 2026-09-29. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Italy reported first (2025-01-31), with Austria following roughly 17 months later — a pattern typical of supply problems cascading between national markets. Registers in Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Diamicron MR 30 mg Tabletten mit veränderter Wirkstofffreisetzung | 2026-06-11 | — | — | register ↗ |
| 🇪🇸 Spain | Shortage GLICLAZIDA NORMON 30 mg COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos + 1 more productsGLICLAZIDA VIATRIS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos | 2025-11-27 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage GLICLAZIDE AUROBINDO + 3 more productsGLICLAZIDE AUROBINDO GLICLAZIDE EG STADA GLICLAZIDE MYLAN GENERICS ITALIA | 2025-01-31 | — | Problemi produttivi (carenza relativa solo al canale retail) Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Gliclazida in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | GLICLAZIDE MYLAN GENERICS ITALIA | Shortage | 2026-08-15 | — | Problemi produttivi |
| 🇪🇸 ES | GLICLAZIDA VIATRIS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 | Shortage | 2026-07-19 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇦🇹 AT | Diamicron MR 30 mg Tabletten mit veränderter Wirkstofffreisetzung | Limited availability | 2026-06-11 | — | |
| 🇮🇹 IT | GLICLAZIDE EG STADA | Shortage | 2026-01-01 | — | Problemi produttivi |
| 🇪🇸 ES | GLICLAZIDA NORMON 30 mg COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 c | Shortage | 2025-11-27 | — | Existen otros medicamentos con el mismo principio activo y m |
| 🇮🇹 IT | GLICLAZIDE AUROBINDO | Shortage | 2025-02-28 | — | Problemi produttivi (carenza relativa solo al canale retail) |
| 🇮🇹 IT | GLICLAZIDE AUROBINDO | Shortage | 2025-01-31 | — | Problemi produttivi |
Yes. As of 7 August 2026, availability issues are reported in: Austria, Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-29 to 2026-09-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
6 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Gliclazida: BASG (Austria), AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Gliclazida — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/gliclazida/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Gliclazida availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/gliclazida/">Gliclazida shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>